Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
about
A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings: Case report and literature review.Role of microRNAs in primary central nervous system lymphomas.Occam's Razor Need Not Apply: A Case of Concurrent Cryptococcal Meningitis and Primary Central Nervous System Lymphoma in an Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patient.Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System.(1)H-MRS is useful to reinforce the suspicion of primary central nervous system lymphoma prior to surgery.Primary Central Nervous System Lymphoma.Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms.
P2860
Q31127156-4BCDA44B-C993-4355-9AE0-AA0F1D664AACQ38779730-C610D422-BE77-4E70-98D1-930EA6A64D75Q40808913-0C0AD5D3-CF3E-4FFF-8366-875F957AD9EDQ41295485-9848F03D-740D-47AC-B5FE-31478F35D7E3Q48657962-1D782BB9-0505-48B2-91A4-C8574AE55CC3Q54846028-364FCCC2-ED63-4F23-B467-158058A42898Q55260453-A90E39B6-91B6-42B6-8868-48D21C5D34F2
P2860
Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Utility of proton MR spectrosc ...... factive demyelinating lesions.
@en
Utility of proton MR spectrosc ...... factive demyelinating lesions.
@nl
type
label
Utility of proton MR spectrosc ...... factive demyelinating lesions.
@en
Utility of proton MR spectrosc ...... factive demyelinating lesions.
@nl
prefLabel
Utility of proton MR spectrosc ...... factive demyelinating lesions.
@en
Utility of proton MR spectrosc ...... factive demyelinating lesions.
@nl
P2093
P2860
P356
P1476
Utility of proton MR spectrosc ...... factive demyelinating lesions.
@en
P2093
P2860
P304
P356
10.3174/AJNR.A3677
P577
2013-08-08T00:00:00Z